Public source
Reviewed 9 Jun 2026
Completeness Fair (33%)
Pyclari AI
EXINIPyclari AI is a software solution for quantitative analysis and standardized reporting of PSMA PET/CT images in prostate cancer. It automatically detects, segments, and quantifies lesions and disease burden, supporting image interpretation.
No papers to support — we monitor for new evidence.
Key features
PSMA PET/CT scans
General Information
Product name
Company
Modality
Main task
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Not verified by Health AI Register
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Deployment
Not specified
Trigger for analysis
Not specified
Processing time
Not specified
Population
Not specified
Market Presence
On market since
Not specified
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Public | First published: Mar 31, 2026 | Last updated: Jun 9, 2026